Equities

Panacea Life Sciences Holdings Inc

PLSH:PKC

Panacea Life Sciences Holdings Inc

Actions
  • Price (USD)0.10
  • Today's Change0.00 / 0.00%
  • Shares traded700.00
  • 1 Year change-41.86%
  • Beta3.2266
Data delayed at least 15 minutes, as of Nov 08 2024 19:38 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Panacea Life Sciences Holdings, Inc. is a holding company organized as a plant-based natural health ingredient and product company. It specializes in the development, manufacturing, research, and distribution of products with natural health and wellness market segment for both humans and animals. The Company’s subsidiary, Panacea Life Sciences, Inc. (PLS) is engaged in the production, distribution, research, and manufacturing of nutraceuticals, cannabinoids, mushrooms, kratom, and other natural, plant-based ingredients and products. The Company also offers natural remedies within its branded product lines for every aspect of life, including PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure, and PANA Life. It also operates 51,000 square foot current good manufacturing practice (cGMP) facility located in Golden, Colorado. The Company, through Panacea Life Sciences Holdings, Inc., manages six retail locations and a distribution center situated in the Tampa, Florida area.

  • Revenue in USD (TTM)2.76m
  • Net income in USD-7.67m
  • Incorporated2008
  • Employees40.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Bespoke Extracts Inc1.05m-1.15m1.56m10.00------1.49-0.1126-0.11260.1029-0.21362.5715.4320.63104,678.00-280.87------44.94---109.44--0.0643-35.39----22,933.72--63.98------
Altamira Therapeutics Ltd59.60k-224.50k1.57m10.000.61080.1752--26.280.67880.67880.03372.370.008-0.19973.365,960.18-2.99-66.27-5.77-113.27150.61---376.67-25,125.900.4268--0.0634------89.86------
Mallinckrodt PLC1.96bn917.30m1.60m2.80k----0.00150.000820.1920.2179.8752.210.46411.684.83698,892.9021.76-12.4925.91-15.8533.7735.6846.88-44.381.83-0.01380.6286---2.53-10.31-83.00------
Procyon Corp4.98m-312.97k1.63m19.00--0.7512--0.3274-0.0387-0.03870.61380.28171.472.329.90262,338.40-10.081.19-12.701.4478.0774.40-6.840.86912.41--0.00--6.353.53-367.38--17.32--
Stemcell Holdings Inc9.98m3.10m1.64m------0.50080.16450.000080.000080.00030.00021.12--5.20--34.90--68.19--77.19--31.04------0.00--85.10--71.82------
cbdMD Inc20.64m-23.42m1.70m52.00--0.5633--0.0826-18.95-18.957.850.80550.88172.0120.35396,856.90-82.98-38.59-112.36-41.5063.4363.80-94.12-87.980.5172-3.890.3128---31.77120.9163.64---4.95--
SOHM Inc-100.00bn-100.00bn1.72m--------------------------------------------------------------
60 Degrees Pharmaceuticals Inc441.25k-2.03m1.82m3.001.04----4.140.94550.94550.63362.980.07550.83552.09147,083.30-27.71------15.59---366.89--2.74--0.0505---50.40--35.51------
Agentix Corp0.00-326.32k2.00m-----------0.0081-0.00810.00-0.0680.00-------131.20-----------------16.66--------57.41------
InVitro International716.89k6.22k2.05m16.00257.142.80--2.860.00040.00040.04020.03211.15------0.9957.891.098.83----0.86765.90---------5.111.33-87.77-16.14----
Panacea Life Sciences Holdings Inc2.76m-7.67m2.08m40.00------0.7511-0.4554-0.45540.164-0.52550.15371.6210.1369,098.25-42.65-69.04---225.03-139.49-181.62-277.51-505.410.0285-2.124.79--46.59--12.33------
Psyence Biomedical Ltd0.001.52m2.26m------1.49---0.0442-0.04420.00-0.39790.00------1.13--1.20-----------------------2.63------
Scorpius Holdings Inc9.85m-29.57m2.31m82.00--0.0143--0.2349-183.17-200.5653.8951.920.1552--11.08120,061.60-49.90-39.37-59.65-43.1864.27---321.53-1,068.210.3127-43.940.3569--1,789.583.841.96--27.32--
Marizyme Inc364.96k-52.51m2.41m11.00------6.61-0.974-0.9740.004-0.07120.01251.3110.0033,178.18-179.49-59.02-742.64-64.4770.1770.38-14,389.19-9,435.920.038-0.69891.92--176.5999.98-71.22------
Scisparc Ltd0.00-6.96m2.45m3.00--6.88-----1.22-1.510.000.03440.00----0.00-92.51-69.39-152.41-111.07-------527.17----0.9371--113.73---97.61------
Data as of Nov 08 2024. Currency figures normalised to Panacea Life Sciences Holdings Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.